Hyperhomocysteinemia is an independent risk for cardiovascular disease. Most of the reported biological effects of homocysteine (Hcy) in vascular cells have been attributed to oxidative mechanisms, which were observed at Hcy concentrations higher than 1mM, and can be mimicked by cysteine, another non-pathogenic biothiol. Thus, a biochemical mechanism unique to Hcy remains to be identified. Our previous work has demonstrated that Hcy at 10-50 muM, but not cysteine, arrests endothelial cell (EC) p21/ras, suppress cyclin A transcription in cell type specific manner. The basic hypothesis of this proposed project is that Hcy, at growth through a hypomethylation related mechanism, which blocks cell cycle progression and endothelium regeneration. This project will study this hypothesis utilizing three linked specific aims. First, in Aim 1, experiments are designed to elucidate the role of Ras demethylation-independent Ras over-expression on EC growth, and on cyclin A expression and promoter activity. Cell growth will be determine by thymidine uptake, flow cytometry and cell counting. Cyclin A expression and promoter activity will be determined by Northern, Western blot analysis and reporter gene transfection. Alternatively, DNA microarray will be used to identify other potential targets in Hcy signaling. Second, in Aim 2, studies are proposed to determine the biochemical mechanisms by which Hcy suppress cyclin A transcription. Experiments will be performed to study the RB phosphorylation and E2F expression, and the role of E2F and other transcription factors on cyclin A transcription by Western blot, reporter gene transfection, gel mobility shift, adenovirus-transduced E2F expression. The role of cyclin A in maintaining RB phosphorylation will be assessed by RNA interference. The promoter methylation pattern of cyclin A genes will be examined by bisufite genomic sequence and methylation sensitive restriction enzyme digestion. Finally, in Aim 3, a mouse endothelial denudation and regeneration model will be used in cystathionine beta-synthase (CBS) knockout and diet-induced hyperhomocysteinemic mice to assess the effect of Hcy in endothelial regeneration. Mouse blood will e examined for the concentrations of Hcy and SAH/SAM. Immunohistochemistry staining for leukocytes, macrophages, EC and smooth muscle cells will be performed on vessel sections to analyze the cellular composition of the lesion. In situ hybridization of immunohistochemistry staining for cyclin A will be performed to assess its involvement. The broad, long-term objective of this proposal i to elucidate Hcy signaling in EC growth inhibition, and to evaluate its importance on the role of atherogenesis in hyperhomocysteinemia. If we identify the key events in Hcy-induced arteriosclerosis, genetic or biochemical approaches to block these steps could lead to therapeutic advantage.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL067033-03
Application #
6729889
Study Section
Experimental Cardiovascular Sciences Study Section (ECS)
Program Officer
Ershow, Abby
Project Start
2002-04-05
Project End
2006-03-31
Budget Start
2004-04-01
Budget End
2005-03-31
Support Year
3
Fiscal Year
2004
Total Cost
$413,875
Indirect Cost
Name
Baylor College of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Cueto, Ramon; Zhang, Lixiao; Shan, Hui Min et al. (2018) Identification of homocysteine-suppressive mitochondrial ETC complex genes and tissue expression profile - Novel hypothesis establishment. Redox Biol 17:70-88
Cheng, Zhongjian; Shen, Xinggui; Jiang, Xiaohua et al. (2018) Hyperhomocysteinemia potentiates diabetes-impaired EDHF-induced vascular relaxation: Role of insufficient hydrogen sulfide. Redox Biol 16:215-225
Xu, Yanjie; Xia, Jixiang; Liu, Suxuan et al. (2017) Endocytosis and membrane receptor internalization: implication of F-BAR protein Carom. Front Biosci (Landmark Ed) 22:1439-1457
Yang, Jiyeon; Fang, Pu; Yu, Daohai et al. (2016) Chronic Kidney Disease Induces Inflammatory CD40+ Monocyte Differentiation via Homocysteine Elevation and DNA Hypomethylation. Circ Res 119:1226-1241
Xi, Hang; Zhang, Yuling; Xu, Yanjie et al. (2016) Caspase-1 Inflammasome Activation Mediates Homocysteine-Induced Pyrop-Apoptosis in Endothelial Cells. Circ Res 118:1525-39
Liu, Suxuan; Xiong, Xinyu; Thomas, Sam Varghese et al. (2016) Analysis for Carom complex, signaling and function by database mining. Front Biosci (Landmark Ed) 21:856-72
Nelson, Jun; Wu, Yi; Jiang, Xiaohua et al. (2015) Hyperhomocysteinemia suppresses bone marrow CD34+/VEGF receptor 2+ cells and inhibits progenitor cell mobilization and homing to injured vasculature-a role of ?1-integrin in progenitor cell migration and adhesion. FASEB J 29:3085-99
Cheng, Zhongjian; Jiang, Xiaohua; Pansuria, Meghana et al. (2015) Hyperhomocysteinemia and hyperglycemia induce and potentiate endothelial dysfunction via ?-calpain activation. Diabetes 64:947-59
Liu, Suxuan; Xiong, Xinyu; Zhao, Xianxian et al. (2015) F-BAR family proteins, emerging regulators for cell membrane dynamic changes-from structure to human diseases. J Hematol Oncol 8:47
Tan, Hongmei; Shi, Chengwei; Jiang, Xiaohua et al. (2014) Hyperhomocysteinemia promotes vascular remodeling in vein graph in mice. Front Biosci (Landmark Ed) 19:958-66

Showing the most recent 10 out of 39 publications